Titre:rarecells - isolation of circulating tumor cells by iset easy-rapid-efficient
La description :a revolutionary method for isolation by size of epithelial tumor cells. rarecells commercialize the patented iset (isolation by size of epithelial/throphoblastic tumor cells - originally metagenex) d...
Server:Apache...
L'adresse IP principale: 212.129.21.102,Votre serveur United Kingdom,London ISP:Online S.A.S. TLD:com Code postal:gb
Ce rapport est mis à jour en 06-Aug-2018
Created Date: | 2010-02-26 |
Changed Date: | 2017-01-02 |
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte rarecells.com.Actuellement, hébergé dans United Kingdom et son fournisseur de services est Online S.A.S. .
Latitude: | 51.508529663086 |
Longitude: | -0.12574000656605 |
Pays: | United Kingdom (gb) |
Ville: | London |
Région: | England |
ISP: | Online S.A.S. |
domaine | Titre |
---|---|
rarecells.com | rarecells - isolation of circulating tumor cells by iset easy-rapid-efficient |
isolation-renovation-murs.fr | solution isolation : isolation des murs, isolation des combles, isolation par l' |
isonat.com | isolation thermique, isolation phonique, isolation acoustique - isonat |
cti-isolation.com | isolation montréal | isolation résidentiel et commercial | cti isolation |
isolation-de-la-toiture.fr | isolation de la toiture par détuilage. isolation par sarking |isolation de la to |
comble-isolation.fr | net renov isolation de comble, isolation toiture, bretagne rennes, vannes, saint |
pacte-solidarite-isolation.com | le pacte solidarité isolation : votre isolation intérieure, surface illimitée, p |
messent.fr | isolation thermique poitiers - messent sas : isolation toiture, niort, tours, la |
dubois-isolation.com | travaux isolation, villefranche sur saône, vienne, grenoble - dubois isolation e |
jmg-isolation.fr | isolation toiture & mur près d'arras béthune et saint-omer - jmg isolation |
dubois-isolation71.com | travaux isolation, villefranche sur saône, vienne, grenoble - dubois isolation e |
nord-loire-isolation.com | nord loire isolation | calorifuge et isolation à nantes saint-nazaire |
isolationecoplus.com | isolation écoplus | isolation de maison intérieure, extérieure, sous-sol | dunha |
ma-toiture.com | techni toit isolation, expert en couverture et isolation près d’arras |
kerviche.com | isolation rénovation peinture morbihan | kerviche troadec | isolation - rénovat |
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
Content-Length: | 4659 |
Content-Encoding: | gzip |
Set-Cookie: | PHPSESSID=kepfum77362su6kad0ruigmqi4; path=/ |
Expires: | Thu, 19 Nov 1981 08:52:00 GMT |
Vary: | Accept-Encoding |
Keep-Alive: | timeout=10, max=100 |
Server: | Apache |
Connection: | Keep-Alive |
Pragma: | no-cache |
Cache-Control: | no-store, no-cache, must-revalidate, post-check=0, pre-check=0, public |
Date: | Mon, 06 Aug 2018 12:43:59 GMT |
Content-Type: | text/html |
soa: | a.dns.gandi.net. hostmaster.gandi.net. 1482525690 10800 3600 604800 10800 |
txt: | "v=spf1 include:_spf.google.com include:servers.mcsv.net ~all" |
ns: | c.dns.gandi.net. b.dns.gandi.net. a.dns.gandi.net. |
ipv4: | IP:212.129.21.102 ASN:12876 OWNER:AS12876, FR Country:FR |
mx: | MX preference = 30, mail exchanger = alt1.aspmx.l.google.com. MX preference = 50, mail exchanger = aspmx2.googlemail.com. MX preference = 10, mail exchanger = aspmx.l.google.com. MX preference = 30, mail exchanger = alt2.aspmx.l.google.com. |
scientific technology by rarecells home company profile contact us welcome to rarecells diagnostics it has been demonstrated that ctcs circulate in blood months and years before the development of metastases, thus their sensitive and diagnostic detection allows diagnosing invasive cancers before the tumor mass becomes detectable by imaging, to set up an early treatment and to avoid recurrence and metastases. iset® - isolation by size of tumor cells note: the medical device and consumables that allow performing the iset® test, previously distributed by metagenex , are now exclusively produced and distributed by rarecells diagnostics. the rarecells® system (medical device and consumables) extracts from blood the rare circulating tumor cells (ctcs) and circulating tumor microemboli (ctm) with an unparalleled sensitivity and without modifying their morphological integrity. for patients : intact ctcs/ctm are further exposed to an in vitro diagnostic examination (eg. cytopathology or other characterization methods such as immuno-labeling, genetic and molecular dna and rna analysis). the rarecells® system allows performing the iset® test, the most rapid, safe, easy to use, reliable and efficient test, with the following specifications: unbiased isolation of intact of ctcs/ctm from all types of cancer isolation of both epithelial and mesenchymal tumor cells sensitivity of 1 tumor cell in 10 ml of blood preservation of the morphological integrity of ctcs/ctm possibility to count ctcs/ctm and to do multiplexing of characterization methods (i.e. multiples analyses performed on the same blood sample) possibility to store ctcs/ctm for at least 7 years after capture and to develop a biobank for their further characterization try the iset® test and the rarecells system, the filtration method that really works! general invasion scheme : latest news biomedicine academy 2018 - attend the scientific presentation of prof. paterlini-brchot, scientific advisor of rarecells diagnostics - july the 30th, 2018 at 11:30 am posted on 28/07/2018 ispd 22nd international conference on prenatal diagnosis and therapy - attend the scientific presentation of prof. paterlini-brchot, scientific advisor of rarecells diagnostics - july the 10th, 2018 at 10:30 am posted on 07/07/2018 6th international molecular diagnostics europe 2018 congress - attend the scientific presentation of prof. paterlini-brchot, scientific advisor of rarecells diagnostics - may the 22nd, 2018 at 3:15 pm posted on 19/05/2018 meet rarecells diagnostics - 11th internal symposium on minimal residual cancer - at booth #4 - 02-05 may 2018, le corum, montpellier, france posted on 30/04/2018 medics 2018 - attend the keynote of prof. paterlini-brchot, scientific advisor of rarecells diagnostics - april the 21st, 2018 at 10:00 am posted on 18/04/2018 company profile videos events design & conception © 2018 rarecells - all rights reserved home | ctc isolation | ctc characterization | advantages & applications | iset products | iset publications home | company profile | contact us | legal
http://www.rarecells.com/iset-products.html
http://www.rarecells.com/competitive-advantage.html
http://www.rarecells.com/news/ispd-22nd-international-conference-on-prenatal-diagnosis-and-therapy-attend-the-scientific-presentation-of-prof-paterlinibrechot-scientific-advisor-of-rarecells-diagnostics-july-the-10th-2018-at-1030-am-146.html
http://www.rarecells.com/iset-publication.html
http://www.rarecells.com/news/meet-rarecells-diagnostics-11th-internal-symposium-on-minimal-residual-cancer-at-booth-4-0205-may-2018-le-corum-montpellier-france-143.html
http://www.rarecells.com/legal.html
http://www.rarecells.com/contact.html
http://www.rarecells.com/ctc-characterisation.html
http://www.rarecells.com/news/biomedicine-academy-2018-attend-the-scientific-presentation-of-prof-paterlinibrechot-scientific-advisor-of-rarecells-diagnostics-july-the-30th-2018-at-1130-am-148.html
http://www.rarecells.com/templates/media/schema5-xl.png
http://www.rarecells.com/news/medics-2018-attend-the-keynote-of-prof-paterlinibrechot-scientific-advisor-of-rarecells-diagnostics-april-the-21st-2018-at-1000-am-142.html
http://www.rarecells.com/accueil.html
http://www.rarecells.com/ctc-isolation.html
http://www.rarecells.com/templates/media/iset_diagnostics.flv
http://www.rarecells.com/news/6th-international-molecular-diagnostics-europe-2018-congress-attend-the-scientific-presentation-of-prof-paterlinibrechot-scientific-advisor-of-rarecells-diagnostics-may-the-22nd-2018-at-315-pm-144.html
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: RARECELLS.COM
Registry Domain ID: 1586808744_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2017-01-02T11:27:22Z
Creation Date: 2010-02-26T17:38:53Z
Registry Expiry Date: 2018-02-26T17:38:53Z
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: abuse@support.gandi.net
Registrar Abuse Contact Phone: +33.170377661
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: A.DNS.GANDI.NET
Name Server: B.DNS.GANDI.NET
Name Server: C.DNS.GANDI.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-10-09T01:37:21Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Gandi SAS
SERVERS
SERVER com.whois-servers.net
ARGS domain =rarecells.com
PORT 43
TYPE domain
RegrInfo
DOMAIN
NAME rarecells.com
CHANGED 2017-01-02
CREATED 2010-02-26
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
A.DNS.GANDI.NET 173.246.98.1
B.DNS.GANDI.NET 213.167.229.1
C.DNS.GANDI.NET 217.70.179.1
REGISTERED yes
La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.